Risk Factors for Endometrial Cancer among Women with a BRCA1 or BRCA2 Mutation: A Case Control Study

PURPOSE: BRCA mutation carriers may use tamoxifen for breast cancer prevention or treatment. Hormone replacement therapy is often prescribed after surgical menopause and oral contraceptives are recommended for ovarian cancer prevention. The objective of this study was to assess the impact of these m...

詳細記述

保存先:
書誌詳細
出版年:Fam Cancer
主要な著者: Segev, Yakir, Rosen, Barry, Lubinski, Jan, Gronwald, Jacek, Lynch, Henry T., Moller, Pal, Kim-Sing, Charmaine, Ghadirian, Parviz, Karlan, Beth, Eng, Charis, Gilchrist, Dawna, Neuhausen, Susan L., Eisen, Andrea, Friedman, Eitan, Euhus, David, Ping, Sun, Narod, Steven A.
フォーマット: Artigo
言語:Inglês
出版事項: 2015
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4962606/
https://ncbi.nlm.nih.gov/pubmed/25838159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10689-015-9798-8
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料